tgAAVCF: Began Phase II trial

The start of the study triggered a $2 million milestone payment to TGEN from

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE